Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-20

Clinical Trial Update: The Quality of Life and Viral Control Effect of AIDS Patients After Long-acting Injection of Cabotegravir and Rilpivirine

View source ↗

Summary

This update reports on a not-yet-recruiting clinical trial evaluating long-acting cabotegravir and rilpivirine in AIDS patients, focusing on viral control and q…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cabenuva (cabotegravir + rilpivirine) (cabotegravir and rilpivirine)

Snippet

Sponsor: National Taiwan University Clinical Trial Center | Conditions: Viral Control, Quality of Life | Status: NOT_YET_RECRUITING